Search Results - "Elkamhawy, Ahmed"

Refine Results
  1. 1

    The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer by Elkamhawy, Ahmed, Lu, Qili, Nada, Hossam, Woo, Jiyu, Quan, Guofeng, Lee, Kyeong

    “…Discoidin domain receptor (DDR) is a collagen-activated receptor tyrosine kinase that plays critical roles in regulating essential cellular processes such as…”
    Get full text
    Journal Article
  2. 2

    Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer by Nada, Hossam, Elkamhawy, Ahmed, Lee, Kyeong

    Published in Molecules (Basel, Switzerland) (21-01-2021)
    “…Pathological angiogenesis is a hallmark of cancer; accordingly, a number of anticancer FDA-approved drugs act by inhibiting angiogenesis via different…”
    Get full text
    Journal Article
  3. 3

    Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments by Antar, Samar A., Ashour, Nada A., Sharaky, Marwa, Khattab, Muhammad, Ashour, Naira A., Zaid, Roaa T., Roh, Eun Joo, Elkamhawy, Ahmed, Al-Karmalawy, Ahmed A.

    Published in Biomedicine & pharmacotherapy (01-12-2023)
    “…Nowadays, diabetes mellitus has emerged as a significant global public health concern with a remarkable increase in its prevalence. This review article focuses…”
    Get full text
    Journal Article
  4. 4

    Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations by Nada, Hossam, Elkamhawy, Ahmed, Lee, Kyeong

    Published in PeerJ (San Francisco, CA) (07-10-2022)
    “…The rapid spread of the coronavirus since its first appearance in 2019 has taken the world by surprise, challenging the global economy, and putting pressure on…”
    Get full text
    Journal Article
  5. 5

    Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update by Gouda, Noha A, Elkamhawy, Ahmed, Cho, Jungsook

    Published in Biomedicines (03-02-2022)
    “…Parkinson's disease (PD) is a neurodegenerative disorder pathologically distinguished by degeneration of dopaminergic neurons in the substantia nigra pars…”
    Get full text
    Journal Article
  6. 6

    Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR) by Godesi, Sreenivasulu, Lee, Joohan, Nada, Hossam, Quan, Guofeng, Elkamhawy, Ahmed, Choi, Yongseok, Lee, Kyeong

    “…The proto-oncogenic protein, c-KIT, plays a crucial role in regulating cellular transformation and differentiation processes, such as proliferation, survival,…”
    Get full text
    Journal Article
  7. 7

    Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin by Nguyen, Phuong Linh, Elkamhawy, Ahmed, Choi, Young Hee, Lee, Chang Hoon, Lee, Kyeong, Cho, Jungsook

    “…Pharmacological inhibition of the enzyme activity targeting carbonic anhydrases (CAs) demonstrated antiglaucoma and anticancer effects through pH control…”
    Get full text
    Journal Article
  8. 8
  9. 9

    New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights by Elkamhawy, Ahmed, Ali, Eslam M. H., Lee, Kyeong

    “…Lymphocyte-specific protein tyrosine kinase (Lck), a non-receptor Src family kinase, has a vital role in various cellular processes such as cell cycle control,…”
    Get full text
    Journal Article
  10. 10

    Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies by Elkamhawy, Ahmed, Woo, Jiyu, Nada, Hossam, Angeli, Andrea, Bedair, Tarek M, Supuran, Claudiu T, Lee, Kyeong

    “…In recent decades, human carbonic anhydrase inhibitors (hCAIs) have emerged as an important therapeutic class with various applications including antiglaucoma,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies by Lee, Kyeong, Nada, Hossam, Byun, Hyun Jung, Lee, Chang Hoon, Elkamhawy, Ahmed

    Published in Pharmaceuticals (Basel, Switzerland) (30-11-2021)
    “…EphB3 is a major key player in a variety of cellular activities, including cell migration, proliferation, and apoptosis. However, the exact role of EphB3 in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening by Elkamhawy, Ahmed, Ammar, Usama M., Paik, Sora, Abdellattif, Magda H., Elsherbeny, Mohamed H., Lee, Kyeong, Roh, Eun Joo

    Published in Molecules (Basel, Switzerland) (01-09-2021)
    “…Recently, multitargeted drugs are considered a potential approach in treating cancer. In this study, twelve in-house indole-based derivatives were preliminary…”
    Get full text
    Journal Article
  17. 17

    EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor by Elkamhawy, Ahmed, Hassan, Ahmed H.E., Paik, Sora, Sup Lee, Yong, Lee, Hwi-Ho, Shin, Ji-Sun, Lee, Kyung-Tae, Roh, Eun Joo

    Published in Bioorganic chemistry (01-05-2019)
    “…[Display omitted] •Compound 4d is an anti-inflammatory EGFR inhibitor.•Compound 4d inhibits LPS-induced NO, IL-1β, IL-6 and TNF-α production.•Compound 4d…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties by Kaddouri, Yassine, Bouchal, Btissam, Abrigach, Farid, El Kodadi, Mohamed, Bellaoui, Mohammed, Elkamhawy, Ahmed, Touzani, Rachid, Abdellattif, Magda H.

    Published in Pharmaceuticals (Basel, Switzerland) (28-06-2022)
    “…A new family of pyrazole-based compounds (1–15) was synthesized and characterized using different physicochemical analyses, such as FTIR, UV-Visible, 1H, 13C…”
    Get full text
    Journal Article